Please login or register first to view this content.
News
NEWS
Latest News
Domiciliary Oxygen Increases Exercise Capacity in Pulmonary Hypertension
BET Inhibitor Reverses Vascular Remodeling in Pulmonary Arterial Hypertension
Right Ventricular Fibrosis Linked to PA Stiffness in Pulmonary Hypertension
Pulmonary Vascular Distensibility: An Early Marker of Pulmonary Vascular Disease
PH Survival in Chronic Lung Disease Predicted by Echocardiographic Parameters
CMR Imaging Similarities Between Pulmonary Hypertension Subtypes
Lower RVSP Threshold Linked to Mortality Risk in Pulmonary Hypertension
Sildenafil Oral Suspension Now Available to Treat Pulmonary Arterial Hypertension
Mechanical Thrombectomy Device Effectively Treats Intermediate-Risk PE Without Thrombolysis
Upcoming Meetings
JANUARY 24-26
• 24th Annual International Atrial Fibrillation Symposium
Boston, MA
FEBRUARY 6-8
• International Stroke Conference 2019
Honolulu, HI
FEBRUARY 6-9
• Society for Cardiovascular Magnetic Resonance Joint EuroCMR/SCMR Meeting 2019
Bellevue, WA
FEBRUARY 28- MARCH 1
• Cardiovascular Research Foundation (CRF) Chronic Total Occlusion (CTO) Summit 2019
New York, NY
Drug News from MPR
Inclisiran Associated With Sustained LDL-C Reduction in ORION-3 Study
Alirocumab Approved by FDA to Reduce Serious Cardiovascular Event Risk
Is There Evidence to Support Kombucha Health Claims in Humans?
FDA Approves First Generic Versions of Ambrisentan for PAH
Does Ranolazine Potentiate the Effects of ACE Inhibitors, Angiotensin Receptor Blockers?
Icosapent Ethyl Treatment Linked to Significant Reduction in Total CV Events
Antithrombotic Regimens Evaluated in Nonvalvular Afib After ACS or PCI
Does Age Affect Alirocumab Efficacy in Heterozygous Familial Hypercholesterolemia?
How Does Cardiorespiratory Fitness Affect the Risk for T2D?
Heart to Heart: Challenges of Providing Cardiac Care Abroad
Want to read more?
Next post in News
